ArticleslgStudy

science

Indatuximab ravtansine

Indatuximab ravtansine is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Indatuximab ravtansine rather than just read about it. In short: Indatuximab ravtansine (BT062) is an immunomodulator and antineoplastic antibody-drug conjugate. It is the anti-CD138 chimerized MAb (nBT062) linked to the maytansinoid DM4.

Indatuximab ravtansine — main illustration
Indatuximab ravtansine — illustration

Key takeaways

  • Indatuximab ravtansine belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Indatuximab ravtansine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Indatuximab ravtansine from memory before moving on to harder problems.

Reference excerpt

Indatuximab ravtansine (BT062) is an immunomodulator and antineoplastic antibody-drug conjugate. It is the anti-CD138 chimerized MAb (nBT062) linked to the maytansinoid DM4. It is being investigated as part of a treatment for multiple myeloma.

Clinical trials

Multiple Myeloma Preliminary data has been reported in 2013 from an early stage clinical trial in combination with Lenalidomide and Dexamethasone. Follow up data reported "encouraging efficacy" in December 2014.

Other As of December 2014, it is in clinical trials for triple negative metastatic breast cancer and metastatic urinary bladder cancer.

Mechanism of action CD138 (Syndecan-1) is highly overexpressed on various solid tumors and in hematological malignancies, and represents one of the most specific target antigens for identification of multiple myeloma (MM) cells. The antibody part binds to CD138 on the target cells and then the DM4 kills the cell.

See also ImmunoGen, more on DM1/DM4 and the linker used in Indatuximab ravtansine Syndecan 1, the protein encoded by SDC1.

References

Illustrations

Indatuximab ravtansine illustration

Worked examples

Example 1 — a first encounter with Indatuximab ravtansine

Start with the simplest possible case. Write down what Indatuximab ravtansine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Indatuximab ravtansine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Indatuximab ravtansine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Indatuximab ravtansine

In research
Indatuximab ravtansine appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Indatuximab ravtansine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Indatuximab ravtansine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antibody–drug conjugate, Drugs not assigned an ATC code, Experimental cancer drugs, so understanding it makes those chapters shorter.
In everyday life
Look for Indatuximab ravtansine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Indatuximab ravtansine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Indatuximab ravtansine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Indatuximab ravtansine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Indatuximab ravtansine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Indatuximab ravtansine in simple terms?

Indatuximab ravtansine (BT062) is an immunomodulator and antineoplastic antibody-drug conjugate. It is the anti-CD138 chimerized MAb (nBT062) linked to the maytansinoid DM4.

Why does Indatuximab ravtansine matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Indatuximab ravtansine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Indatuximab ravtansine.

Tags

  • Antibody–drug conjugate
  • Drugs not assigned an ATC code
  • Experimental cancer drugs
  • Monoclonal antibodies for tumors

Keep exploring